BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23042210)

  • 1. Effect of kidney dysfunction on cortical thinning in patients with probable Alzheimer's disease dementia.
    Cho EB; Seo SW; Kim H; Lee JM; Yoon U; Im K; Kim GH; Noh Y; Cho H; Yoon CW; Kim HJ; Na DL
    J Alzheimers Dis; 2013; 33(4):961-8. PubMed ID: 23042210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical thinning related to periventricular and deep white matter hyperintensities.
    Seo SW; Lee JM; Im K; Park JS; Kim SH; Kim ST; Ahn HJ; Chin J; Cheong HK; Weiner MW; Na DL
    Neurobiol Aging; 2012 Jul; 33(7):1156-67. PubMed ID: 21316813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked cerebral atrophy is correlated with kidney dysfunction in nondisabled adults.
    Yakushiji Y; Nanri Y; Hirotsu T; Nishihara M; Hara M; Nakajima J; Eriguchi M; Nishiyama M; Hara H; Node K
    Hypertens Res; 2010 Dec; 33(12):1232-7. PubMed ID: 20944639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cerebral small vessel disease with delusions in patients with Alzheimer's disease.
    Ogawa Y; Hashimoto M; Yatabe Y; Kaneda K; Honda K; Yuuki S; Hirai T; Ikeda M
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):18-25. PubMed ID: 22396307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topography of cortical thinning areas associated with hippocampal atrophy (HA) in patients with Alzheimer's disease (AD).
    Kim GH; Jeon S; Seo SW; Kim MJ; Kim JH; Roh JH; Shin JS; Kim CH; Im K; Lee JM; Qiu A; Kim ST; Na DL
    Arch Gerontol Geriatr; 2012; 54(2):e122-9. PubMed ID: 22088936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors cause cortical thinning in cognitively impaired patients: relationships among cardiovascular risk factors, white matter hyperintensities, and cortical atrophy.
    Seo SW; Lee JM; Im K; Park JS; Kim SH; Kim ST; Ahn JH; Kim MJ; Kim GH; Kim JH; Roh JH; Cheong HK; Na DL
    Alzheimer Dis Assoc Disord; 2012; 26(2):106-12. PubMed ID: 21946011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of demographic factors on cortical thickness in Alzheimer's disease.
    Seo SW; Im K; Lee JM; Kim ST; Ahn HJ; Go SM; Kim SH; Na DL
    Neurobiol Aging; 2011 Feb; 32(2):200-9. PubMed ID: 19321233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in cortical thickness with dementia severity in Alzheimer's disease.
    Im K; Lee JM; Seo SW; Yoon U; Kim ST; Kim YH; Kim SI; Na DL
    Neurosci Lett; 2008 May; 436(2):227-31. PubMed ID: 18400396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Richards BA; Chertkow H; Singh V; Robillard A; Massoud F; Evans AC; Kabani NJ
    Neurobiol Aging; 2009 Oct; 30(10):1626-36. PubMed ID: 18261828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.
    Doddy RS; Massman PJ; Mawad M; Nance M
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and anatomical correlates of gait dysfunction in Alzheimer's disease.
    Olazarán J; Hernández-Tamames JA; Molina E; García-Polo P; Dobato JL; Álvarez-Linera J; Martínez-Martín P;
    J Alzheimers Dis; 2013; 33(2):495-505. PubMed ID: 23011219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic normal-pressure hydrocephalus, cortical thinning, and the cerebrospinal fluid tap test.
    Kang K; Yoon U; Lee JM; Lee HW
    J Neurol Sci; 2013 Nov; 334(1-2):55-62. PubMed ID: 23938354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type.
    Seo SW; Ahn J; Yoon U; Im K; Lee JM; Tae Kim S; Ahn HJ; Chin J; Jeong Y; Na DL
    J Neuroimaging; 2010 Jan; 20(1):37-45. PubMed ID: 19220710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease.
    Singh V; Chertkow H; Lerch JP; Evans AC; Dorr AE; Kabani NJ
    Brain; 2006 Nov; 129(Pt 11):2885-93. PubMed ID: 17008332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of SVM methods with surface-based cortical and volumetric subcortical measurements to detect Alzheimer's disease.
    Oliveira PP; Nitrini R; Busatto G; Buchpiguel C; Sato JR; Amaro E
    J Alzheimers Dis; 2010; 19(4):1263-72. PubMed ID: 20061613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
    Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
    Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal thinning of the cerebral cortex in multiple sclerosis.
    Sailer M; Fischl B; Salat D; Tempelmann C; Schönfeld MA; Busa E; Bodammer N; Heinze HJ; Dale A
    Brain; 2003 Aug; 126(Pt 8):1734-44. PubMed ID: 12805100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease.
    Cho H; Jeon S; Kang SJ; Lee JM; Lee JH; Kim GH; Shin JS; Kim CH; Noh Y; Im K; Kim ST; Chin J; Seo SW; Na DL
    Neurobiol Aging; 2013 Jul; 34(7):1921.e9-1921.e15. PubMed ID: 23391426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A voxel-based morphometric study of cortical gray matter volume changes in Alzheimer's disease with white matter hyperintensities.
    Ha SY; Youn YC; Kim S; Hsiung GY; Ahn SW; Shin HW; Park KY; Park TH; Kim SS; Kee BS; Kwon OS
    J Clin Neurosci; 2012 Nov; 19(11):1506-10. PubMed ID: 22989793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.